Product Information
ATORVASTATIN 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0245 per EA under NDC 16571013610. Its NADAC has been published 122 times since Feb 28, 2024.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571013610
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209912On Market Since
10/20/2023
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 10 MG TABLET has been published 122 times since Feb 28, 2024, and over the history we have for it it has declined 18.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0245 per EA |
|---|---|
| All-time high | $0.0340 (Apr 10, 2024) |
| All-time low | $0.0224 (Nov 20, 2024) |
| 52-week high | $0.0277 |
| 52-week low | $0.0245 |
| Median price | $0.0258 |
| Average price | $0.0267 |
| Largest weekly change | -25.9% (Apr 17, 2024) |
| Weeks tracked | 122 |
| Tracking since | Feb 28, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0245 per EA (NDC 16571013610), effective Jun 24, 2026.
How has the price of ATORVASTATIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 10 MG TABLET has declined 18.6%. It has been tracked across 122 weekly CMS publications since Feb 28, 2024.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 10 MG TABLET?
Since Feb 28, 2024, the NADAC for ATORVASTATIN 10 MG TABLET has ranged from a low of $0.0224 (Nov 20, 2024) to a high of $0.0340 (Apr 10, 2024), with a median of $0.0258 per EA.
Are there cheaper alternatives to ATORVASTATIN 10 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ATORVASTATIN 10 MG TABLET, but none are currently priced below it.
Who manufactures ATORVASTATIN 10 MG TABLET?
ATORVASTATIN 10 MG TABLET (NDC 16571013610) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification